Biological Aspects of Dosimetry
In the previous section the physical principles of calculations of absorbed dose from internal emitters have been outlined. For such calculations, biological data are required and problems in securing these data are discussed in this section.
In principle, the biological data required to calculate the radiation dose received by any organ or tissue of the body, following administration of a particular radioactive preparation, include the variation with time of activities in all parts of the body and the mass and size and relative locations of the source and target regions. In practice, any model (Brownell et al., 1968 ) set up to represent the distribution of activity and its changes with time will necessarily be incomplete but should be refined as new data become available.
Detailed data on the metabolism of many radiopharmaceuticals in human subjects are still comparatively sparse, much of the available information being derived from experiments on animals. Data are, of course, required both on the metabolism of particular radionuclides in ionic form and as constituents of the various pharmaceuticals in clinical use. Knowledge of the rate of breakdown of a pharmaceutical into constituents is also needed, so that allowance can be made for the appearance of the radionuclide in chemical forms differing from that originally administered.
Ideally, therefore, the information required is a complete knowledge of the tracer kinetics of the system. This may, for example, be a compartmental model showing the fraction of the administered activity entering each compartment, the turnover time and the rates of flow from one compartment to others. In practice, the information available may be very limited; e.g., for oral administration, data may be available only for the fraction transferred from the gut to the blood, and in some cases the fraction retained in certain organs, the rate of elimination from those organs and also the rate of elimination from the body.
It must also be noted that there are marked variations in physiological data between normal and diseased states and between children and adults; these variations may radically affect the concentrations of radionuclides in particular organs and their variation with time. In addition, the concentrations may be affected by the specific activity of the administered radioactive material or by the administration of chemical agents, which modify the biological function of particular organs.
Distribution of Activity in the Body
Following Administration of Radiopharmaceuticals
Observations on Animals
In preliminary investigations of any new radiopharmaceutical the first step will almost always consist of experiments on laboratory animals. Total body radioactivity measurements, the assay of specimens of blood and excreta, and, after the animals are killed, the assay of activity in a large number of organs and tissues may be required. The last can sometimes best be obtained blood in "· CCIVO myacard. liver intestines Fig. 3.1 (a) . Autoradiogram showing the distribution of tritium labelled dihydrostreptomycin in a mouse 5 minutes after intravenous injection. This is a reproduction of a print from a negative and white areas correspond to darkening on the original autoradiogram and indicate high dihydrostreptomycin contents. The high concentration in blood and kidney should be noted. Ilford G.5. plates. Exposure time 5 months. (Andre, 1956.) (With acknowledgements to the publishers of Acta Radiologica for permission to reproduce.) .
by quantitative autoradiographic studies (Andre, 1956) ( Figure 3 .1), particularly when the compound under study is labelled with a low-energy ,6-particle-emitter.
From serial measurements a model for the variation with time of the activity in various organs can be constructed. Such an investigation may be expected to indicate, for example, that certain organs show a considerably higher time integral of activity per unit mass than others, and need particular attention in calculations of absorbed dose. Having identified such organs, further study may reveal gross nonuniformity of distribution of activity within the organ whid1, if reproduced in man, might entail at some stage modifications in dose calculations. For some pairs of radionuclides, for example 47 Ca and 47 Sc (Taylor, 1966) , such studies may reveal differences in the metabolism of a daughter radionuclide when administered intravenously alone and when produced in situ by decay of a parent radionuclide in bone. Such experiments may provide the only practicable way to obtain data on the distribution of a radiopharmaceutical in body tissues. This is especially true for those ,6-particle-emitting radionuclides which cannot be detected outside the body, and for which analysis of excreta and blood in samples from patients yields incomplete results. The main problems concern extrapolations of the data to man, as the pattern of distribution in the two species may be different. This problem is discussed by Trott et al. (1975) Data on the distribution of the stable elements in man have provided considerable guidance in predicting possible sites of concentration of particular radionuclides. Much detailed information is given in the report on "Reference Man" (ICRP, 1975) . However, in attempting to apply such data in investigations with radioactive tracers it is necessary to note that:
(a) There are large variations between individuals on account of the differing environments and diets to which they have beeri exposed. (b) The chemical form of the element in the diet or the environment will seldom be the same as that of the administered radioactive material. (c) The distributions in the body of the stable element and its radioisotopes will usually differ because of the differences in the rate of biological turnover at particular sites in the body, e.g., 3 2 P will only be taken up in bone which is actively being laid down at the time of administration and because of radioactive decay, the bone phosphorus will not be uniformly labelled. Consequently, although data on the distribution of stable elements can be of value, investigations on humans with the radioactive preparations of interest are essential for setting up realistic models for dose calculations.
Investigations on Human Subjects
In investigations on the distribution of particular radioactive preparations in human subjects it is possible to make only a limited number of measurements, and to determine the pattern of turnover in the body for a limited number of organs and tissues. It is, therefore, important to focus attention on the most relevant measurements, bearing in mind that the data which are most readily available are those obtained in day-to-day clinical work.
The techniques of measurement required for radiation dosimetry do not differ in principle from those used in diagnostic work, although to obtain information on the absorbed dose received by several organs of the body a greater number of organs will generally need to be studied over a longer period of time than is usually necessary in clinical tests. In addition, in those diagnostic tests which depend only on the kinetics of the administered tracer, e.g., the use of 1 3 1 I sodium o-iodohippurate in investigations of kidney function, more attention has to be given to the calibration of detectors, since in measurements made for dosimetry it is necessary to know the actual radioactive content in particular organs as well as its variation with time (Henk et al., 1967) . No special problems arise in meeting this requirement in the assay of specimens but in vivo measurements present greater difficulty. The measurement of radioactivity in body organs has been reviewed by an international panel (IAEA, 1971 a, b) and certain relevant features of the techniques described there are outlined in the following sections.
The initial distribution following a single administration of radioactive material, once it has entered the circulation, will be largely determined by the fractionation of the cardiac output between the various organs and tissues. In the absence of metabolism or excretion, the material will ultimately be distributed according to the sizes of the labile or exchangeable pools in the various tissues. However, the actual fraction of the administered tracer taken up by a given organ will be governed also by its own metabolic activity and by the presence of other tissues competing for the same material, notably the excretory organs; the radioactive half-life of the nuclide will often determine which of these distribution processes are the more important. The range of data required for calculations of absorbed dose will be governed by the relative importance of these factors. Thus, when the physical half-life of the nuclide is only a few hours, interest will center primarily on the abllorbed dose received by the whole body and those of its organs where there is a rapid selective uptake. For example, 99 Tcm-labelled macro-aggregated albumin is Illustration of pattern of turnover of a labelled radiopharmaceutical, derived from measurements on patients using a profile counting system. The figure shows uptake and clearance curves for the 1 3 1 I content of several organs, following the administration of 131 1 macroaggregated albumin; the data have not been corrected for physical decay (Galt and Tothill, 1973) .
concentrated in the lungs immediately after intravenous injection. Clearance from the lungs may be slow compared with the rate of radioactive decay, so the subsequent fate and distribution of released materials is relatively unimportant for radiation dosimetry (Galt and Tothill, 1973) (see Figure 3 .2). The data in this figure relate to 131 I-labelled macro-aggregated albumin, but, in the absence of more direct information, it may be assumed that the difference of label will not affect the behaviour in the lungs in the first few hours. A similar situation occurs when a long-lived nuclide is administered in a form that is rapidly excreted, but here it is the biological mean time that is the important factor, and this needs to be measured in the individual patient, since it may vary considerably with disease state. The dose to the kidneys and bladder following the administration of 13 11 sodium o-iodohippurate provides an example; in this case the 8-day half-life of the radionuclide is irrelevant. Also, when the radioactive half-life is relatively long, it becomes necessary to pay attention to tissues whose uptaJ<e may be small but which have a slow turnover rate, for example, the uptake of 22Na in bone. This implies long-term measurements and the use of very sensitive equipment. It also follows from these considerations that the concentration of activity as a function of time in the blood may be quite different from that in the tissue being perfused. This sometimes means that the contributions to the absorbed dose received by a particular organ from activity in the tissue and from activity in the contained blood may have to be evaluated separately, especially when the radionuclide is a pure /)-particle emitter. Cloutier and Watson (1970) have discussed these problems in some detail.
It must be emphasized that the uptake and distribution of a given amount of activity administered to the patient will usually depend on its chemical form, specific activity, physical form and route of administration. These factors can profoundly influence the absorbed dose and its distribution and need to be specified in every case. Appendix C gives some typical data for 99Tcm.
(a) Measurement of whole-body activity and its variation with time (i) Accumulated measurements of excreta. The most generally applicable method for the determination of the whole-body content and the mean transit time (or the biological disappearance constant) of the radiopharmaceutical in the body, is to measure the total activity excreted in urine, feces and sometimes expired air as a function of time and estimate the retention by difference. In practice, however, this method must usually be restricted to short-term studies on rapidly excreted substances. It is very inaccurate in conditions where a fraction of the administered activity is excreted slowly, because of the relatively large errors in estimates of this fraction that result from almost inevitable losses during collection of excreta.
(ii) Measurements of specific activity. An indication of the excretion pattern can sometimes be obtained without complete collections of excreta by measurements of the specific activity of the radionuclide in spot samples of body fluids or excreta as a function of time, e.g., 59 Fe in plasma, 3 H in urine water, 14 C in expired carbon dioxide (Roberts et al., 1958; Tolbert and Cozzetto, 1964) . Where the excretion pattern can be represented as a single exponential component, the specific activity is proportional to the total activity of the radionuclide in the body but this is not so when there are several pools with different turnover rates, since each will have a different constant of proportionality which may, in some cases, approach zero. Thus, measurements of specific activity in excreta cannot provide information regarding the presence, or amount, of radioactivity which may be taken up by particular tissues and permanently retained in the body. The specific activity is the quotient of the activity and a defined mass. This may be, for example, the total mass of a specimen of fluid or the mass of a particular element contained in that specimen.
(iii) Whole-body counting. At present it appears that whole-body counting techniques will provide the greatest amount of useful data so far as )'-ray-emitting nuclides are concerned. High-energy /)-particle-emitting radionuclides such as 32 P can be detected by bremsstrahlung counting, but the sensitivity is about two orders of magnitude lower than is obtainable with many )'-ray-emitting radionuclides. Serial measurements over as long a period as practicable are the most useful since they can indicate the existence of a "tail"
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on the activity-time curve which may represent a substantial contribution to the total radiation dose. For example, the absorbed dose to bone following the administration of 22 Na comes predominantly from the long retention of a small fraction of the activity. For radiopharmaceuticals administered orally, serial measurements will often provide a direct measure of the fraction of the administered activity assimilated from the gut.
In investigations of the change of activity retained with time, the chief problem arises from the effects on the calibration factor (the activity per unit counting rate) of redistribution of radioactive material in the body. The magnitude of these effects depends on the configuration of the detector system and they are most marked for)' rays of energy less than about 100 keV. It is unsatisfactory to use counting systems for which the calibration factor, although high, shows substantial variations with distribution of the radionuclide. As has been pointed out on a number of occasions (Miller and Marinelli, 1956; Cederquist and Liden, 1962; Naversten, 1966) , the so-called "chair geometry" counter systems are usually unsatisfactory for this type of measurement. The preferable arrangements of detectors include (a) large-area liquid or plastic scintillators approaching a 27r or 47r configuration, (b) multiple scintillation counters arranged to minimize the variation of sensitivity with source position, (c) scanning systems and (d) arc configurations of the body in which the distal surface of the body is at a constant distance from a single detector. To minimize the effects of the variable concentration of radioactivity it is nearly always necessary to make measurements from both sides of the body, either by having detectors above and below, or by turning the patient over. If the latter procedure is used in conjuction with an arc configuration, a comparatively large radius of arc will have to be used, thus limiting the sensitivity that can be achieved.
While use of the whole-body counter arrangements described may reduce to acceptable proportions variations of calibration factor due to changes in position of the source in a nonabsorbing medium, the problem of attenuation remains. Errors introduced by attenuation may be reduced by selecting a wide energy band in the scintillation spectrum for measurements (Miller and Marinelli, 1956; Cederquist and Liden, 1962; Naversten, 1966; Warner and Oliver, 1966; Dudley and hen Haim, 1968; Cottrall et al., 1973) . For example, the count rate obtained from a source of 59 Fe has been found empirically to be almost independent of depth and body thickness if an energy band of 0.2 to 1.5 Me V is used. Confining counting to the total absorption peak in the scintillation spectrum can give rise to large errors. Table  3 -1 illustrates some studies on the effect of distribution of activity on relative values of the calibration factor for various systems of whole body radioactivity measure- Characteristics of individual types of whole-body counters have been considered in many publications, and the IAEA has prepared a comprehensive list of such apparatus (IAEA, 1970) ; details of construction and sensitivity are given, although no critical review is undertaken. The proceedings of various conferences are also a useful guide to the subject (e.g., IAEA, 1966) .
(b) Measurement of activity in particular organs and tissues (i) Kinetic analysis of whole-body retention data. When the total activity in the body plotted against time gives a curve that may be resolved into several compo-0.89 0.85 0.89 0.87 0.47 0.44 0.47 0.45 0.39 0.38 0.41 0.38 nents with widely differing half-lives, it is often possible to attribute one or more of these components to a particular tissue by utilizing previous physiological knowledge. This applies particularly to the components with longest retention, which are important from the point of view of dosimetry. The fraction of the administered activity taken up in a particular tissue can be estimated in this way provided the whole-body counter is equally sensitive to activity in different parts of the body. This approach is useful when dealing with tissues that are widely distributed in the body (e.g., fat, reticuloendothelial system, skeleton) but cannot be precisely localized anatomically.
(ii) Localized counting with fixed detectors. While many well established clinical diagnostic techniques involve measurements with a collimated scintillation detector over particular organs, or sites, it is comparatively uncommon for such tests to require estimation of the activity present, although in theory this should be possible by calibration using a suitable model of the part of the body concerned (i.e., a phantom). In practice, the distribution of activity throughout the phantom should effectively correspond with that in the body in both its morphological and dynamic aspects. If both the organ and, in turn, the phantom containing the source can be completely included within the field of view of the collimator, it is less important to ensure their identity of size and shape than if only a fraction of either is included. The effect of differences of depth of the source below the skin between the organ and the phantom can be minimized by increasing the distance between the detector and skin. However, this leads to a loss of sensitivity and for a given activity and detector system, it is necessary to compromise on a distance which minimizes the errors due to the combination of geometrical uncertainty and counting statistics.
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One of the simplest measurements is represented by radioiodine uptake in the thyroid gland and this has been studied very thoroughly. Even though the requirements were carefully limited to a single radionuclide (131 I) at a particular time (24 hours) after administration (ICRU, 1963; Trott et al., 1968) , a considerable effort was needed to establish a reliable method of measurement. Besides the problems of unknown depth and extent of the organ, counting with fixed detectors often leads to difficulties related to activity outside the volume of interest, for example, in circulating blood and extracellular tissue. Fava and Buraggi (1963) made a valuable study of the use of narrow and broad angle collimators in such measurements.
(iii) Profile counting or linear scanning. Techniques of profile counting (linear scanning) using a collimator which accepts radiation only from a relatively narrow slice of the body have, for a long time, been applied to present a one-dimensional picture of the activity localized at particular sites (Pochin, 1950; Corbett et al., 1956) . The method offers much greater sensitivity than two-dimensional visualization (see below), so that smaller activities may be measured, and rapid dynamic changes may be more readily followed. There have been several descriptions of profile counters using scintillation detectors, which offer greater sensitivity and the possibility of energy discrimination (Morris, 1960; Pircher et al., 1960 Pircher et al., , 1962 Alfrey, 1967) . A report of IAEA (1971 a,b) contains a summary of the properties of profile counters and their calibration.
It is, again, desirable that the calibration of the counter be substantially independent of the distribution of the radionuclide in the body. Geometrical independence may be largely achieved by recording counts from both sides of the body. Attenuation effects may, again, be reduced by counting in a wide energy band, but in this type of measurement the inclusion of Compton scatter leads to a loss of positional resolution, so that it is preferable to confine counting to the photo-peak, and record the counts from opposite sides of the body separately. The two sets of counts coupled with a knowledge of the thickness of the patient and the attenuation coefficient of the r rays used, may be manipulated to determine the activity present, relatively independently of the source depth (Tothill and Galt, 1971 ).
(iv) Scanning. Linear and area scanning offer the possibility of assessing the radioactivity in tissues outside the organ of interest. However, a problem arises when the scans from adjacent organs overlap. Serial measurements may be useful, particularly if the concentration is known to be limited to one organ at a particular time. Scans obtained using a second compound having a different ratio of concentration in the two organs may also help to resolve this problem (Cottrall et al., 1969) .
Area scans, which are now carried out clinically in Diameter of summed area /cm Fig. 3.4 . This and the following figure illustrate some of the problems that arise in endeavoring to estimate the activity localized in an organ by means of a rectilinear scanning technique. The curves show counts recorded in the scan, summed over increasing areas, for a 6-cm diameter plane source containing 131 I. Measurements were made in air for several collimator-to-source distances. It will be seen that all the curves approach the same value when the area of summation is made large enough for the detector to scan fully the entire source irrespective of the distance of the source from the collimator. (Arimizu et al., 1969.) many institutions, can be calibrated to provide quantitative information (Hughes-Jones et al., 1957; Laughlin et al., 1964; Laughlin et al., 1969; Williams et al., 1969; Trott et al., 1975) . From the information so far published on the scope and limitations of this technique, the calibration problems do not appear to be as formidable as those encountered with localized counting methods. It will usually be necessary to compare the scan over the patient with the scan of a phantom, but the similarity between model and reality is less important than for stationary counters used in uptake measurements. Work of interest in this field includes the procedures developed by Andros et al. (1965) , and Glass et al. (1972) for determining the activity of 9 9 Tcm localized in the thyroid gland, the quantitative serial scanning techniques described by Trott et al. (1973) and measurements of 52 Fe in bone marrow by Lillicrap et al. (1976) . Techniques of digital computer data analysis of recorded counts reduce the labor involved in such investigations.
Another practical advantage of scanning and )'-camera techniques, is that the total number of counts recorded from a source with area exceeding a minimum size determined by the collimator design is independent of the distance between source and detector, provided that the effect of attenuation in overlying tissue is negligible. The effects of attenuation may be minimized Diameter of summed area I cm Fig. 3 .5. This is an extension of Figure 3 .4, showing the effect of choice of energy band. The curves show the accumulated response to plane sources of 131 I at 10-cm depth in water. All sources had the same activity. The net counts in the scan records were summed over circles of various diameters on the scan record, with the highest count for the :364 keV total absorption peak, 314-414 keV taken as 100%. The summation curves for counts in this peak level off, as do the curves in Figure 3 .4 for sources in air. Summed integral counts (>50 keV) and summed counts for scattered radiation (100-200 keV) show a continuous increase with increasing area of source. (Arimizu et al., 1969.) or compensated by counting from both sides of the body (Sharma, 1968; Arimizu et al., 1969) . As long as the distribution of radioactivity immediately outside the organ of interest is reasonably uniform, it is not necessary to define closely the boundaries of the organ in order to assess its radioactive content (Figure 3.4) . Perhaps the chief merits of area and linear scanning for estimations of the activity in organs are that the scans themselves serve to localize the source and that allowance can be made for blood and other background activity in overlying tissue (IAEA, 1971 a,b) . Figures 3.4 and 3.5 illustrate some studies of scanning techniques for estimating activity localized in an organ.
(c) Measurement of turnover rate in specific organs and tissues In principle, serial measurements by any of the techniques listed above will provide data from which estimates for metabolic turnover rates or mean transit times for particular tissues can be derived. In practice, if the uptake in an organ has once been determined at a given time, variations with time can usually be ob- served most conveniently using localized counting techniques with a fixed detector, if nearby tissues do not concentrate radioactivity. A correction for the radioactive material in blood and in tissues other than the one under study can be derived in this procedure by using a second detector over a 'neutral' region of the body.
As the variations in activity in blood will usually follow a different pattern from those in the organs of interest (resulting in a change of background with time at a rate that will differ from the rate of change of activity in the organ of interest), analog and digital methods have been developed for the subtraction of the blood background count rate from that arising from the organ of interest. This technique is commonly adopted in the investigation of kidney function by renography. A detector is placed over each kidney and a third over the heart. A proportion of the count rate recorded by the heart detector can be subtracted from each of the others, to allow for extra-renal activity within the field of view of the kidney detectors (Hall and Monks, 1966) .
(d) Sensitivity of in vivo measurement systems For dosimetric purposes it may be necessary to extend measurements of retention of activity in organs and the whole body over long periods and the activity remaining may be only a small fraction of that administered in the test. It is, therefore, necessary to consider 3.2 Organs and Tissues • • • 21 carefully the sensitivity of the counting systems that may be used for such measurements. In clinical work it is often convenient to specify sensitivity not in terms of the well established "minimum detectable activity," but using a quantity that may be called the "minimum measurable activity" (Veall and Vetter, 1958) . This is the activity that can be determined to a specified precision (say 5%) using given periods of measurement of background and of subject (say 1000 s). The sensitivity of any detector depends on the geometrical relationship between the source and the detector, on the efficiency of detection of the radiation incident upon the detector (which together determines the calibration factor) and on the background count rate (IAEA, 1966) .
Other factors influence the sensitivity of scanning and camera systems. The first factor is the relationship between sensitivity and positional resolution; as a collimator designed for good resolution has a poor sensitivity and vice versa. Secondly, the background to be taken into account is most often due primarily to radiation coming from parts of the patient outside the field of interest, rather than from environmental or cosmic-ray background. Thirdly, it is always necessary to scan beyond the limits of the concentration of interest. With linear and area scanners this leads to a reduction of the time available for the accumulation of counts from the organ, and, therefore, to a reduction of sensitivity. This limitation does not apply, in general, to gamma cameras.
Because of these factors, it is difficult to present an accurate comparative assessment of the sensitivity of imaging systems. However, values are given in Table 3 -2 as a rough guide to the relative sensitivities of the instruments considered. The activities listed are the least for a radionuclide emitting one )'-ray photon per nuclear transformation that may be expected to yield useful quantitative results of value in dosimetry for times of measurement (10 to 30 minutes) which are clinically acceptable. These values are about an order of magnitude greater than the minimum detectable For many of the calculations of absorbed dose arising from the administration of radiopharmaceuticals to man, one is trying to predict the dose that will be received by a typical subject rather than attempting to estimate the dose to an individual patient. For such predictive calculations, some standardization of the data is necessary. In some of the earliest works of this type, as exemplified by the studies of Mayneord (1945) and of Bush (1946), it was only necessary to accept a certain value for the total mass, e.g., 70 kg for the "standard man". Increasingly, however, the standard man has been refined to take into account first of all, for the normal adult male or female, the masses of many organs and tissues (ICRP, 1959) and more recently (ICRP, 1975) , a detailed report has been published giving critically analyzed data on values of the mass of individual organs and their dimensions. However, their spatial distribution in the body has not been so extensively examined. The data on these parameters now available make possible more extensive use of the physical data particularly on absorbed fractions and the energy absorption from point sources that have been produced in recent years. Snyder et al. (1969) presented a valuable report on absorbed fractions for photons using a particular model for a standard man in which they included mass, shape and spatial distribution of important organs and tissues. This has recently been extended by Snyder et al. (1975) to provide values for absorbed dose per unit time integral of activity arising from any one of 117 radionuclides assumed retained in individual organs of a model designed to resemble as closely as practicable "Reference Man" (ICRP, 1975) . The individual performing a dose calculation is, of course, at liberty to make whatever assumptions he considers reasonable for these parameters; nevertheless, this report of Snyder et al. (1975) will often prove very convenient in use since the data presented incorporate appropriate calculations of absorbed fractions for the radiation emitted by all the radionuclides dealt with.
Mass of Tissue in Disease States
In disease states there can be gross variations in the masses and shapes of particular organs and considerable error can result from using the data for the standard man. In this connection, area scans can be particularly valuable, especially if they are carried out in two mutually perpendicular planes, since they can be used to estimate approximately the volume over which the radionuclide is distributed in organs such as the liver and spleen (Deland and Wagner, 1972) . However, the problems in relating the images obtained to actual organ dimensions have not yet been completely solved.
Reporting of Results
Once the original clinical purpose in administering a particular radiopharmaceutical to a patient has been achieved, it is often difficult to organize further measurements which may be of value in dosimetry, but not of importance in diagnosis.
This, while perhaps inevitable, is regrettable, since many of the data needed could be secured without exposing the patient to any further administration of a radiopharmaceutical and with relatively little inconvenience to the patient. This being so, it is particularly important that those who have responsibility for considering the ethical aspects of this type of clinical study should be aware of the wider value of the data that can be obtained. The most significant problems arise when the radionuclide used has a comparatively long physical half-life (e.g., 75Se) and then the measurements may need to be carried out over an extended period. The results of such measurements as can be obtained, should be reported in the literature, giving detailed information on the radiopharmaceutical and its mode of administration, the techniques of measurement, t,he observations and the assumptions made in calculating the absorbed dose (see Appendix C).
Sources of Biological Data
This section has been concerned chiefly with a discussion of the various methods that can be used in securing biological data on the pattern of distribution of radiopharmaceuticals in man. Appendix E to this report provides information on sources of such data already available, including work of the ICRP.
